Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – In boys with nonpalpable cryptorchidism, performing ultrasound before surgery to localize the testes is not necessary and shouldn’t be done, two urologists from…
NEW YORK (Reuters Health) – A UK national audit shows that in chronic obstructive pulmonary disease (COPD), non-invasive ventilation (NIV) is often used – or not used –…
NEW YORK (Reuters Health) – A study of Chernobyl survivors shows no difference in recurrence patterns between radiation-related and sporadic thyroid cancers. “Similar treatment approaches should be recommended…
NEW YORK (Reuters Health) – Although large pupil size is viewed by some ophthalmologists as a relative contraindication to undergoing LASIK, preoperative pupil size does not affect quality…
NEW YORK (Reuters Health) – Hypothermia and the medications used with it can influence the common predictors of neurologic outcome after cardiac arrest, according to findings published online…
NEW YORK (Reuters Health) – In a retrospective study of patients with severe sepsis or septic shock, those who received a single-dose of etomidate before rapid sequence intubation…
NEW YORK (Reuters Health) – In a prospective study, the beta-1 selective blocker bisoprolol proved more effective than the non-selective beta-blocker carvedilol in preventing atrial fibrillation after coronary…
NEW YORK (Reuters Health) – Smoking does not affect outcomes after early clopidogrel use in patients with acute coronary syndrome (ACS), according to findings published in the November…
NEW YORK (Reuters Health) – Patients with generalized anxiety disorder (GAD) are best treated with an antidepressant for at least 12 months, according to a study published in…
NEW YORK (Reuters Health) – There’s no need for people to stop taking aspirin before an immunochemical fecal occult blood test (iFOBT) because it won’t hamper the performance…
